$Kiniksa Pharmaceuticals(KNSA.US) is yet another beautiful setup in the $XBI names. You don't even look harder. Just search for what XBI holds and randomly pick 5-7 names, there is a high chance all of them look good. All you high tech money is rotating there.
Kiniksa Pharmaceuticals
KNSA80.9201.86% ( +1.480 )
Kiniksa Pharmaceuticals (KNSA)
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom,...
- Open
- 81.430
- High
- 82.940
- Low
- 77.570
- Prev. Close
- 79.440
- Volume
- 1.38M
- Turnover
- 110.89M
- Avg Price
- 80.338
- Bid/Ask Ratio
- --
- Amplitude
- 6.76%
- 52wk High
- 82.940
- Volume Ratio
- 2.12
- Turnover Ratio
- 3.43%
Kiniksa Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jul 29, 2026Price forecast
$96.1318.79%
Forecast & RatingStrong buy
8analysts
- Strong buy87.50%
- Buy12.50%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 4 hours ago
Wedbush Forecasts Strong Price Appreciation for Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock
- rttnews · 19 hours ago
Top Biotech Gainers: KNSA Soars On Q2 Results, TRIB, OPK On Watch, MPLT On The Mend?
- benzinga_article · 1 day ago, 12:06 PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga_article · 1 day ago, 09:05 AM
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday
- Market Beat · 1 day ago, 06:56 AM
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Posts Quarterly Earnings Results, Hits Estimates
- Earnings Watch · 1 day ago, 06:35 AM
Kiniksa Pharmaceuticals | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 243.6 M
